By a News Reporter-Staff News Editor at Marketing Weekly News Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain, announced that DEG..
Woodbridge, Ontario/ TheNewswire/ December 1, 2016- Pivotal Therapeutics Inc.,, a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced today that on October 25, 2016 it received a Statement of Claim from Crossover Healthcare Fund, LLC which was filed in the Ontario Superior Cour
A communication from the Executive Analyst, Department of Health and Human Services, transmitting, pursuant to law, a report relative to a vacancy in the position of Commissioner, Administration on Native Americans, Department of Health and Human Services, received in the Office of the President of the Senate on November 30, 2016; to the Committee
Sunovion Pharmaceuticals Inc. will present four research posters on Latuda and two research posters on novel investigational psychotropic SEP-363856 at the 55 th Annual Meeting of the American College of Neuropsychopharmacology, being held December 4-8 in Hollywood, Florida. Poster M166: A Phase 1 Open Label Safety and Tolerability Study of...
It was developed by China's leading over-the-counter pharmaceutical company, Jiangzhong Group, to enhance the astronauts' immunity during their training and space trips. In the long run, the group plans to make the product available to retailing distribution channels, so that consumers can use it to enhance their health, said Zhong Hongguang, chair
Akers Biosciences, Inc., a developer of rapid health information technologies, has signed a distribution agreement with First Check Diagnostics, LLC, the major global diagnostic device and service provider, to serve as the exclusive distributor of the Company's rapid cholesterol self-test in the United States under their "First Check" brand.
BioPharmX Corporation, a specialty pharmaceutical company developing products for the dermatology market, will share research findings this week that suggest topical minocycline fights P. acnes- induced inflammation in human keratinocytes. The data will be shared in a poster presentation titled "Effects of minocycline against Propionibacterium ac
-Mirixa Corporation, the leading provider of medication-related services to health plans and PBMs, announced that Inland Empire Health Plan has selected Mirixa Corporation and the MirixaPro platform to administer medication therapy management services for the IEHP Pharmacy Home Program. The IEHP Pharmacy Home program is one of the first large-scale
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women's health and respiratory diseases, today announced the launch of UriVarx? in the U.S. UriVarx? is clinically proven to reduce urinary u
-MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm drug delivery technology to improve patient outcomes and to address unmet needs, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to Diazepam Buccal Soluble Film for the treatment of Acute Repetitive Seizures. Securing Orphan Drug.
Equities in today's lineup are: Mylan N.V., Horizon Pharma PLC, Allergan PLC, and Catalent Inc.. Shares in Hertfordshire, the UK- based Mylan N.V. ended Wednesday's session at $36.61, rising 1.53% from the last trading session. On November 18 th, 2016, research firm Mizuho reiterated its' Buy' rating on the Company's stock with a decrease of the ta
COLUMBIA Livestock owners across Missouri are encouraged to prepare for Food and Drug Administration rule changes on antibiotics that will go into effect Jan. 1. Craig Payne, director of veterinary medical extension at the University of Missouri, said there are two main changes. The FDA created a list of antimicrobials in 2003 that are important in
Mirixa Corporation, the leading provider of medication-related services to health plans and PBMs, announced that Inland Empire Health Plan has selected Mirixa Corporation and the MirixaPro platform to administer medication therapy management services for the IEHP Pharmacy Home Program. The IEHP Pharmacy Home program is one of the first large-scale.
Innovus Pharma Signs $2 Million a Year Exclusive License and Distribution Agreement with J&H Co. LTD for Zestra for Female Sexual Arousal in South Korea. SAN DIEGO Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care product
Securing Orphan Drug Designation from the FDA s Office of Orphan Products Development is a significant milestone for MonoSol Rx, said Keith Kendall, CEO of MonoSol Rx. Diazepam is well established as an effective treatment for ARS, but oral administration is challenging given the likelihood that a patient experiencing a seizure will hav
PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November23, 2016, Provectus Biopharmaceuticals, Inc. (the Company) receiv
WATERMARK GROUP, INC. (OTCMKTS:WMHH) Files An 8-K Entry into a Material Definitive Agreement Item 1.01 Entry into a Material Definitive Agreement. The disclosure in Item 2.01 below is incorporated by reference herein. Item 2.01 Completion of Acquisition or Disposition of Assets. On October 13, 2016, we entered into an exclusive license agreement (t
Also include the FDA docket number found in brackets in the heading of this document. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Section 1701 of the Public Health Service Act authorizes the FDA to conduct research relating to healt
Zestra is currently exclusively partnered with Orimed Pharma in Canada, DanaLife in select European markets, Sothema Labs for the Middle East and North Africa, Elis Pharma in Turkey and certain select markets, Oz Biogenics for Myanmar and Vietnam, Biotask in Malaysia and non-exclusively to PT in Hong Kong and certain select Asian markets.
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women s health and respiratory diseases, today announced the signing of an exclusive license and distribution agreement with J&H Co. LTD for t
Vancouver, BC- M Pharmaceutical Inc.,, is providing a preview of the business strategy for the commercialization of its recently acquired C-103 Project. Orlistat is FDA- approved for weight management and sold by Roche as Xenical? and by GlaxoSmithKline as alli?. The drugs are not systemically absorbed, have strong safety profiles and are appro
Orlistat is FDA- approved for weight management and sold by Roche as Xenical and by GlaxoSmithKline as alli. The drugs are not systemically absorbed, have strong safety profiles and are approved by the FDA. This approach is possible in light of the previous FDA approval for Rx Xenical in 1999..
This application follows the successful completion of a pivotal pharmacokinetic study and a productive meeting with the FDA earlier this year, said Dan Barber, Vice President of MonoSol Rx. We believe that our product is well-positioned to compete in the multi-billion dollar erectile dysfunction market, based on its status as the first alternative
*Congress will keep its promise to the American people to repeal and replace Obamacare. *Last year, Congress passed a reconciliation bill that demonstrates how we can repeal the core parts of Obamacare with a transition to replace. Of those who are insured, many can't afford care due to sky-high deductibles, and most of the newly insured are insure
According to the FDA, in 2012, the agency began issuing compliance policy guides regarding antibiotic usage in animal agriculture. This led to the FDA taking a new approach on the judicious use of medically important antibiotics in food-animal production. "The FDA implemented these guides in response to growing concern about antimicrobial resistan